Computational Bio & Chem

Showing 1–14 of 14

DCVC Leads $14 Million Seed Round for Noetik

By James Hardiman

Deep Tech Opportunities Report

Predictive drug development: toward efficacy from the get-to

DCVC leads $12M financing for Kanvas Biosciences to map the human body’s undiscovered territory: the microbiome

By Jason Pontin

DCVC leads $13 million seed funding for ShennonBio—revolutionizing immunotherapy through immune cell profiling at unprecedented accuracy, speed

By James Hardiman

DCVC Announcements

DCVC Welcomes 2022

Biology-as-a-Platform in the Fight Against Cancer: Freenome Raises $270m Series C

By Zachary Bogue

DCVC Announcements

2021 and Deep Tech: Reasons for Optimism

Using Biology-as-a-Platform to Move from Treatment to Cure

By Zachary Bogue

Life sciences and Deep Tech: The next set of solutions to the next set of problems

By Dr. Kiersten Stead, Dr. John Hamer, Matthew Ocko, Zachary Bogue

An Update on How Deep Tech is Arming the Fight Against COVID-19

By Matthew Ocko, Zachary Bogue

Powering a Comprehensive Response to the COVID-19 Crisis Through Deep Tech

By Matthew Ocko, Zachary Bogue

Reimagining biologics: AbCellera and Novartis partner to find new disease treatments

By Dr. John Hamer

AbCellera Raises $10M Series A: Deep Search for the Immune System

By Matthew Ocko, Zachary Bogue

DCVC Bio leads GenEdit’s $8.5 Million Seed Round: Safe, efficient CRISPR and gene therapy delivery platform proven across multiple diseases and cell types

By Matthew Ocko, Zachary Bogue

Explore Content Topics

View All

Computational Bio & Chem 14

Computational Healthcare 16

Cybersecurity, Security, & Defense 11

Enterprise Enablement 6

Finance & Insurance 1

Foundational Technology 4

Industrial Transformation 23

Smart Agriculture 11